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Abstract
Background: Very little is known about the range of diagnoses, course of treatment and long-term outcome in
elderly patients who choose to receive homeopathic medical treatment. We investigated homeopathic practice in
an industrialised country under everyday conditions.
The aim of the study was to determine the spectrum of diagnoses and treatments, as well as to describe the
course of illness over time among older patients who chose to receive homeopathic treatment.
Methods: In this subgroup analysis of a prospective, multicentre cohort study totally including 3981 patients
treated by homeopathic physicians in primary care practices in Germany and Switzerland, data was analysed from
all patients > 70 years consulting the physician for the first time. The main outcome measures were: assessment by
patient of the severity of complaints (numeric rating scales) and quality of life (SF-36) and by the physician of the
severity of diagnoses (numeric rating scales) at baseline, and after 3, 12, and 24 months.
Results: A total of 83 patients were included in the subgroup analysis (41% men, mean age 73.2 ± (SD) 3.1 years;
59% women, 74.3 ± 3.8 years).
98.6 percent of all diagnoses were chronic with an average duration of 11.5 ± 11.5 years. 82 percent of the
patients were taking medication at baseline.
The most frequent diagnoses were hypertension (20.5%, 11.1 ± 7.5 years) and sleep disturbances (15.7%, 22.1 ±
25.8 years).
The severity of complaints decreased significantly between baseline and 24 months in both patients (from 6.3 (95%
CI: 5.7-6.8) to 4.6 (4.0-5.1), p < 0.001) and physicians’ assessments (from 6.6 (6.0-7.1) to 3.7 (3.2-4.3), p < 0.001); qual-
ity of life (SF 36) and the number of medicines taken did not significantly change.
Conclusion: The severity of disease showed marked and sustained improvements under homeopathic treatment,
but this did not lead to an improvement of quality of life. Our findings might indicate that homeopathic medical
therapy may play a beneficial role in the long-term care of older adults with chronic diseases and studies on
comparative effectiveness are needed to evaluate this hypothesis.
Background
Homeopathy is one of the most frequently used but con-
troversial forms of complementary and alternative medi-
cine (CAM). It is based on the ancient ‘principle of
similars’. Highly diluted preparations of substances that
cause symptoms in healthy individuals are used to stimu-
late healing reactions in patients who display similar
symptoms when ill [1]. In classical homeopathy a single
homeopathic remedy is selected, based on a patient’s
total spectrum of symptoms [2]. The proportion of
patients obtaining homeopathic care has quadrupled in
the last seven years according to a US survey [3]. For
Germany a recent survey demonstrated that approxi-
mately 10% of men and 20% of women in the general
population used homeopathic medicines during the pre-
vious year [4]. To date, few studies have evaluated the
use of complementary therapies in geriatric patients [5].
In Germany, 73% of adults over 60 years of age use
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any medium, provided the original work is properly cited.naturopathic drugs [6,7]. There is little information about
the safety and efficacy of these interventions, especially if
they are combined with conventional therapies [8].
This project was designed with the goal of systemati-
c a l l yc o l l e c t i n gd a t ai nt h i sa r e ao fh o m e o p a t h i ch e a l t h
care for the first time in Germany.
The aim of the present study was to determine the
spectrum of diagnoses and treatments, as well as to
describe the course of illness over time among older
patients who chose to receive homeopathic treatment.
To collect data on the use and effects of homoeopathy
under conditions of usual care, we investigated 3981
patients in a prospective observational study [9-11]. This
paper presents the results of our evaluation, focusing on
a subgroup of 83 adults over 70 years of age, who con-
sulted a homeopathic physician.
Methods
Study design
In a prospective, multicentre cohort study involving 38
primary care practices with additional specialisation in
homeopathy in Germany and Switzerland, in this sub-
group analysis data was analysed from all patients being
70 years or older consulting the physician for the first
time. Patients were included consecutively at their first
consultation with a participating physician and were fol-
lowed up for a total of 24 months. In order to provide
as representative a picture of homeopathic health care
as possible, patients were included in the study regard-
less of their diagnosis. Sixty-eight percent of all
approached patients agreed to participate in the study.
For description of the selection process see [10].
In order to participate in the study, physicians were
required to have certified training in classical homeop-
athy and at least three years practical experience, they
all followed the principles of classical homeopathy. All
homeopathic physicians worked in their own doctor’s
offices, hospital services were not included. A total of
187 physicians belonging to four different working
groups were contacted either by post or telephone and
informed about the study. Of these, 103 physicians
chose to participate.
All study participants provided written, informed con-
sent, and the study protocol was approved by the appro-
priate ethics review boards [10].
Treatments
To reflect usual care, all homeopathic physicians were
completely free to choose a treatment. This usually
included the prescription of homeopathic medicines
according to homeopathic principles, but could also
include the prescription, change or withdrawal of a con-
ventional medicine, referrals to specialists, or admission
to a hospital.
Outcome measures
All questionnaires were designed to document sociode-
mographic data, as well as information on prior medical
history, patient symptoms and complaints, quality of
l i f e ,a n dt h eu s eo fa n yt r e a t m e n to t h e rt h a nh o m e o p -
athy. At baseline, patients recorded the complaints that
led them to consider homeopathic treatment. Indepen-
dently of their physicians, patients rated the severity of
their complaints as they experienced them on a numeric
rating scale (NRS, 0 = no complaints, 10 = maximum
severity of complaints the patient could imagine for this
disease) [12]. All complaints listed by patients in their
baseline questionnaire were transferred to their follow-
up questionnaires by the study office personnel, which
ensured that each baseline complaint was assessed at
each subsequent follow-up. General health-related qual-
ity of life was assessed using the MOS SF-36 question-
n a i r e[ 1 3 ] .T h er e s u l t so ft h eS F - 3 6a r ep r e s e n t e di n
normalised scores, the results being scaled in such a
way that the normal German population, in the age
group considered, has a mean score of 50 and a stan-
dard deviation of 10. (As quality of life is considerably
lower in this age group than in the whole population
this normalisation should not be confused with a nor-
malisation of the whole German population).
The first questionnaire was distributed to the patients
by the homeopathic physician treating the patient and
completed prior to the start of therapy (baseline). The
ensure this physicians and their nurses were trained in
the in the process and a monitor visited the practice to
check the process during the study. Patients sent their
completed questionnaires to the study office in sealed
envelopes. Follow-up questionnaires were sent to all
patients by the study office at 3, 12, and 24 months.
For physicians, we developed a standardised question-
naire that allowed for continuous documentation during
the treatment/follow-up period (24 months), as well as
standardised points of assessment at 0, 3, 12 and 24
months. At each of these time points the physician saw
the patient and estimated the severity of a maximum of
four diagnoses from their perspective after they did the
case taking with the patient using a numeric rating scale
(NRS, 0 = no complaints, 10 = maximum severity of the
occurrence of this diagnosis) [13]. This information was
then forwarded to the study office. The type of homeo-
pathic treatment, the use of any conventional therapy,
as well as any referrals to other physicians were
recorded on a continuous basis.
Statistics
We calculated the severity of complaints (patients’
assessments) and diagnoses (physicians’ assessments), by
averaging those four complaints/diagnoses named first
for each patient during the baseline examination. At
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tive severity ratings were ascertained.
All results reported here are based on the intention-to-
treat approach, i.e. each patient included in the study
entered the final analyses. If patients dropped out or with-
drew from the study we replaced the respective missing
values: baseline complaints that had been cured were
given a severity rating of 0 in all following examinations.
For patients who died during the study, we inserted
the maximum severity rating of 10. Consequently,
any improvements are possibly underestimated, but cer-
tainly not overestimated. Other missing values were multi-
ply imputed following the suggestions of Rubin [14].
Instead of filling in a single value as a substitute for a miss-
ing value, multiple imputation is a strategy by which each
missing value is replaced simultaneously by a set of plausi-
ble values that represents the uncertainty about the right
value to impute. Thus, each missing values is filled in sev-
eral times generating several distinct data tables, each with
a complete set of data relating to all patients without any
missing values. These complete data tables are analysed
separately using appropriate statistical models. Afterwards,
the results from all statistical analyses are pooled to gener-
ate treatment effects and p-values. In our study we used
the MCMC (Marcov chain Monte Carlo) replacement
method and created 5 multiple imputed data tables.
For each imputed data set, treatment effects were esti-
mated on the basis of generalised linear regression mod-
els. Generalised linear regression models are flexible and
powerful tools to describe data from cohort studies [15].
They are generalisations of the well known and often
applied multiple regression models which often appear to
be too simple to describe longitudinal data adequately. A
generalised linear model is best described by two compo-
nents. First, the mean course of the outcome, and second,
the correlation structure for measurements taken on the
same individual at different times. In our study we
divided the 2-year follow-up period into two parts. Dur-
ing the first part (0-3 month) we assumed that mean out-
come increased (or decreased) linearly. For the second
part (3-24 months) we assumed that the mean outcome
increased (or decreased) according to a quadratic term.
Moreover, we assumed that the correlation between two
measurements could be described by a simple exponen-
tial function. This essentially means that the correlation
only depended on the time span between the two mea-
surements, and it decreased the larger this time span was.
This approach is completely analogous to the recommen-
dations given by Diggle, Liang, and Zeeger in their stan-
dard text book on the analysis of longitudinal data [15].
Usually, patients for clinical studies are not selected
randomly from a target population but according to
some selection criteria by which patients are sampled
according to extreme measurements (high blood
pressure, severe pain, low quality of life, ...). This inevita-
bly leads to regression-to-the-mean, a statistical phe-
nomenon that makes natural variation look like real
changes [16]. Separating regression-to-the-mean effects
from true treatment effects can be difficult but is at
least feasible when the mean and the standard deviation
of the target population are known [17]. In our study
we made a rather conservative assumption on the target
population (chronically ill patients seeking homeopathic
care): to have the same quality of life as the general Ger-
man population (i.e. a mean SF-36 score of 50 and a
standard deviation of 10). From this we calculated the
expected regression-to-the mean effect and compared it
to the total change in quality of life, hereby applying
Mee and Chua’s modified t-test [17].
Although this study is explanatory by nature confi-
dence intervals and p-values for change scores might
be misinterpreted as statistical proof of hypotheses. We
thus adjusted the results for all 12 outcomes (4 outcome
measures times 4 time points) by applying Holm’sp r o -
cedure [18].
Standardized mean changes (effect sizes) were calcu-
lated by mean changes divided by standard deviation at
baseline.
Results
Patients were recruited between September 1997 and
December 1999. Thirty-eight primary care physicians
(33% of all participating doctors) reported treatment of
adults over 70 years of age.
We have included 83 adults in this study, 59% (n = 49)
women, age 70 - 87 years (mean 74.3 ± 3.1 SD) - and
41% men (n = 34), age 70 - 84 years (mean 73.2 ± 3.1) in
the present analysis. For baseline characteristics of
the study population see Table 1.
98.6 percent of all diagnoses were chronic with an
average duration of 11.5 ± 11.5 years.
At baseline on average 3.0 ± 1.1 initial diagnoses
(2.9 ± 1.1 of them chronic) were made. Fifty-seven per-
cent of the patients had five or more complaints at
Table 1 Baseline characteristics of study sample of older
adults (> 70 years) under homeopathic treatment (n =
83)
Gender (% female) 59.0
Age (years, mean ± SD) 73.9 ± 3.6
Living alone in household (%) 31.0
Living together with a partner (%) 66.3
Education (% attending school > 10 years) 28.9
Strong belief in homeopathy (%) 65.1
Duration of disease (years, mean ± SD) 11.5 ± 11.5
Intake of conventional drugs (%) 81.9
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sion (21%) and sleep disturbances (16%). The most com-
mon diagnosis in women was sleep disturbance (22.4%)
and in men hypertension (26.5%). For the most frequent
diagnoses, their severity and duration is shown in
Table 2.
All patients underwent an initial homeopathic consul-
tation, lasting an average of 110 ± 36 minutes. During
the 24-month observation period following the initial
interview, patients consulted their physicians an average
of 6.3 ± 6.3 times. The average period of treatment
lasted 10 ± 9.1 months. Nine patients died during fol-
low-up, the mean survival time was 376 days (range 6 to
725 days). Twenty patients stopped the homeopathic
treatment. The reasons given were aggravation (n = 13),
amelioration (n = 3), outcome unrelated reasons (n = 2)
and no report (n = 2). During the study period eight
patients (9.6%) were referred to non-study physicians
(excluding dentists).
Each patient received on average 6.1 ± 5.3 (not neces-
sarily different) homeopathic remedies. Prescriptions
were given consecutively following the principles of clas-
sical homeopathy. More than half of all prescriptions
were covered by 9 homeopathic remedies (Figure 1).
The most frequently prescribed homeopathic potencies
were C200 (31.3%), C1000 (13.5%), C30 (12.7%) and Q1
(9.9%). Eighty-two percent of the patients were taking
medication at baseline (38% cardiovascular, 16% for cen-
tral nervous system, 16% gastrointestinal and metabolic,
30% others), the number of prescribed drugs remained
stable across 24 months (baseline: mean 2.6 ± 2.2 (SD);
3 months: 2.3 ± 2.0; 12 months: 2.0 ± 2.2; 24 months
2.3 ± 2.1).
The strongest clinical improvements of complaints
were described by patients in the first three months,
after which no further improvement was observed
(Table 3, Figure 2). Complaint severity decreased signifi-
cantly (p < 0.001) from 6.3 (95%CI: 5.7-6.8) to
Table 2 Most frequent diagnoses, disease severity and disease-duration in the study population of older adults
(> 70 years) under homeopathic treatment
Disease (ICD 9) Frequency
% (n)
Disease severity
(Physicians Assessment)
(NRS 0-10)
Mean ± SD
Disease Duration
(years)
Mean ± SD
Hypertension (401.9) 21 (17) 5.7 ± 1.7 11.1 ± 7.5
Sleep Disturbance (780.5) 16 (13) 7.1 ± 2.3 22.1 ± 25.8
Diabetes mellitus (250.0) 7 (6) 5.8 ± 1.5 8.0 ± 7.2
Sciatica (724.3) 7 (6) 5.7 ± 2.7 15.1 ± 16.3
Low Back Pain (724.2) 6 (5) 4.8 ± 2.3 19.0 ± 8.3
Osteoarthritis (715.3) 6 (5) 3.6 ± 1.5 9.5 ± 9.7
Depression (311.0) 6 (5) 5.8 ± 1.5 6.4 ± 6.7
Figure 1 Most frequently prescribed homeopathic drugs in the study sample of older adults (> 70 years; in %).
Teut et al. BMC Geriatrics 2010, 10:10
http://www.biomedcentral.com/1471-2318/10/10
Page 4 of 84.6 (4.0-5.1) at 24 months. The physicians’ assessments
of diagnoses showed a more optimistic course for the
long term, decreasing from 6.6 (6.0-7.1) to 3.7 (3.2-4.3;
p < 0.001) (Table 3, Figure 2). Small but significant
improvements in quality of life were observed on the
SF-36 mental component scale during the first three
months of treatment (p = 0.036). This significance how-
ever vanished if regression-to-the-mean was accounted
for (p = 0.062, Mee-Chua-test). Overall the quality of
life remained stable within the 24 months observation
period. (Table 3). Again, no treatment effects could be
confirmed that exceeded regression-to-the-mean effects
(all p > 0.1).
Discussion
In a prospective multicentre observational study with
qualified homeopathic physicians in daily practice, we
documented the homeopathic and conventional treat-
ment with its outcome in 83 elderly patients over
24 months.
The study provided information on the course of dis-
ease in elderly patients receiving homeopathic treat-
ment, as assessed by both patients and physicians.
Patient and physician assessments of the severity of the
complaints consistently demonstrated substantial
improvements following homeopathic treatment, which
were maintained through 24 months of follow up. Overall
Table 3 Outcome: Complaints, effect size, quality of life (estimated means and confidence intervals from the statistical
model) in the study sample of older adults (> 70 years) under homeopathic treatment
STATUS Month 0 Month 3 Month 12 Month 24
SEVERITY (NRS, All Diagnoses, Mean and 95% CI)
Complaints
a 6.27
(5.70; 6.84)
4.31
(3.71; 4.90)
4.41
(3.87; 4.95)
4.57
(4.03; 5.10)
Diagnoses
b 6.57
(6.03; 7.11)
4.77
(4.23; 5.30)
4.63
(4.09; 5.16)
3.72
(3.19; 4.26)
QUALITY OF LIFE (SF-36 Component Scores, Mean and 95% CI)
Physical 38.37
(34.26; 42.47)
39.22
(35.11; 43.32)
38.86
(34.81; 42.90)
36.32
(32.29-40.35)
Mental 46.22
(41.56; 50.88)
49.59
(44.91; 54.27)
47.62
(43.04; 52.21)
46.02
(41.46; 50.58)
CHANGE
c
Months 0-3 p
c Months 0-12 p
c Months 0-24 p
c
SEVERITY (NRS, All Diagnoses, Mean and 95% CI)
Complaints
a -1.96
(-2.67;-1.25)
< 0.001 -1.87
(-2.86; -0.88)
< 0.001 -1.71
(-2.83; -0.59)
< 0.001
Diagnoses
b -1.80
(-2.39; -1.21)
< 0.001 -1.94
(-2.71; -1.17)
< 0.001 -2.84
(-3.72; -1,96)
< 0.001
QUALITY OF LIFE (SF-36 Component Scores, Mean and 95% CI)
Physical 0.85
(-1.20; 2.90)
1.00 0.49
(-3.08; 4.06)
1.00 -2.05
(-6.86; 1.76)
1.00
Mental 3.37
(0,62; 6.12)
0.036 1.40
(-3.29; 6.09)
1.00 -0,20
(-6.41; 6.01)
1.00
STANDARDIZED MEAN CHANGE
c
Months 0-3 p
c Months 0-12 p
c Months 0-24 p
c
SEVERITY (NRS, All Diagnoses, Mean and 95% CI)
Complaints
a -1.21
(-1.65; -0.77)
< 0.001 -1.15
(-1.76; -0.54)
< 0.001 -1.05
(-1.74; -0.36)
< 0.001
Diagnoses
b -1.08
(-1.44; -0.72)
< 0.001 -1.17
(-1.64; -0.70)
< 0.001 -1.72
(-2.25; -1.19)
< 0.001
QUALITY OF LIFE (SF-36 Component Scores, Mean and 95% CI)
Physical 0.05
(-0.07; 0.17)
1.00 0.03
(-0.17; 0.23)
1.00 -0.11
(-0.38; 0.16)
1.00
Mental 0.16
(0.02-0.30)
0.036 0.07
(-0.16; 0.30)
1.00 -0.01
(-0.32; 0.30)
1.00
a Complaints = Patients’ Assessment;
b Diagnoses = Physicians’ Assessment
c p-values and confidence intervals were multiply adjusted to maintain an overall level of significance of 5%. However, due to the nature of this study they
should only be interpreted as exploratory.
NRS = Numerical Rating Scale: 10 = maximum, 0 = no complaints. Negative change in NRS indicates improvement. Positive quality of life change indicates
improvement.
Absolute effect size > 0.8, large; > 0.5, medium; > 0.2, small.
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remained stable within the 24 months observation period.
To our knowledge, the present study is the first to sys-
tematically evaluate the range of diagnoses and therapies
in classical homeopathic medical practices in Germany
and Switzerland in patients over 70 years old. A strength
of this study is that patients with all diagnoses were
included. Therefore, no disease-specific measurement
instruments could be used. To assess the severity of dif-
ferent medical complaints, there is no other generally
accepted measuring instrument available. Instead
numerical rating scales [12] were applied, which would
allow for the determination of the severity of the com-
plaint in a diagnosis-independent manner. However, our
data may be helpful in the planning of further research
on homeopathy including randomized clinical trials on
the effectiveness of individually chosen homeopathic
remedies. These trials however should include tailored
instruments which measure treatment effects more spe-
cifically than the rather global measures we employed in
this study.
Our study was not designed to assess the effectiveness
of the homeopathic remedies, therefore the chosen
methodology did not include a control group, randomi-
zation or blinding and patients could use additional con-
ventional therapies. Thus, the observed improvement
c a nb ea t t r i b u t e dt oaw i d er a n g eo fp o s s i b l er e a s o n sa s
it is known for complex interventions. Our findings
might indicate that homeopathic medical therapy may
play a beneficial role in the long-term care of older
adults with chronic diseases and studies on comparative
effectiveness are needed to evaluate this hypothesis.
There might be some selection bias because the
homeopaths belong to a group using only classical
homeopathy. Other forms of homeopathy, for example,
clinical homeopathy are more focused on the primary
disease symptoms, treat more often acute diseases and
have shorter case taking and use a smaller range of
homeopathic drugs. In addition information bias might
be possible because we follow the assumption that miss-
ing values are per random, this might result in a under-
estimation or overestimation of effect. A further
Figure 2 Disease severity in study population of older adults (> 70 years) under homeopathic treatment over 24 months.
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elderly patients had a strong belief in homoeopathy.
This might have triggered the therapeutic outcome due
to high therapeutic expectations.
It is of special note that in this study the average
severity of the chronic diseases was reduced by approxi-
mately 30% after only three months of homeopathic
treatment, and remained at about this level during the
follow-up period. Physician assessments tended to be
more positive than patient assessments. This is sup-
ported by the fact that patients did not visit the study
physicians when they were feeling their worst, but rather
after a long waiting period. The interpretation of our
quality of life results is difficult. The SF-36 baseline
values of our homeopathic patients were lower than in
the German normal population of the same age group
(physical component score - difference: 1.5 and mental
component score: 6.2) [13]. In the German population
SF-36 values for physical and mental component score
decrease with increasing age [13]. Based on this the
absence of a decrease in quality of life in our elderly
patients might be interpreted in a positive way.
We were unable to confirm the common notion that
homeopathy is frequently used for trivial complaints or
diseases. The duration of disease in our study patients
was very long and their symptoms were, on average, of
moderate severity. The spectrum of complaints is clearly
age-related and differs from the total sample of all adult
patients: in women (n = 2017) the most frequent diag-
noses were migraine (9.7%), headache (9.1%), sleep dis-
turbances (7.5%) and eczema (7.3%); in men (n = 834)
allergic rhinitis (10.3%), eczema (7.8%), hypertension
(7.7%) and sleep disturbances (6.5%) [10].
If we compare our results for elderly patients with
other homeopathic outcome studies [9-11,19-21] there is
a common and clinically relevant improvement of the
severity of complaints for most patients over all age-
groups within the first few months of homeopathic treat-
ment. For all 3981 patients in our cohort severity of dis-
ease decreased significantly from 6.2 (SD ± 1.7) to 3.0 (±
2.2), the initial improvement being stable during the 24
month follow-up. Major improvements in quality of life
could only be observed in children, but not in adults. In
our elderly subgroup we can confirm these results.
Conclusion
The findings of our study demonstrate that elderly
patients who seek homeopathic treatment are primarily
those suffering from long-standing, chronic disease.
The severity of complaints decreased markedly in the
first 3 months of treatment. However, the quality of life
remained stable. Our findings might indicate that
homeopathic medical therapy may play a beneficial role
in the long-term care of older adults with chronic
diseases and studies on comparative effectiveness are
needed to evaluate this hypothesis.
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